- Filed
- Jan 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Jan 22, 2025 | 8.52B sh |
| Capex | Q2 2024 · Jun 30, 2024 | $0 |
| Capex | Q2 2024 · Jun 30, 2023 | $0 |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $0 |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $0 |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $69.43K |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $56.43K |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $69.43K |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $56.43K |
| Current Assets | Q2 2024 · Jun 30, 2024 | $0 |
| Current Assets | Q2 2024 · Dec 31, 2023 | $0 |
| Total Assets | Q2 2024 · Jun 30, 2024 | $0 |
| Total Assets | Q2 2024 · Dec 31, 2023 | $0 |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 8.52B sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 8.52B sh |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$22.78K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | −$25.88K |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | −$18.75K |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$2.5K |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.00 |
| Net Income | Q2 2024 · Jun 30, 2023 | −$7.13K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$23.38K |
| Net Income | Q2 2024 · Mar 31, 2023 | −$16.25K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$7.13K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$23.38K |
| Revenue | Q2 2024 · Jun 30, 2023 | $0 |
| Revenue | Q2 2024 · Jun 30, 2023 | $0 |